Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35M | Buy |
|
|||||
|
2025
Q1 | $30.3M | Sell |
|
|||||
|
2024
Q4 | $31M | Buy |
|
|||||
|
2024
Q3 | $27.4M | Buy |
|
|||||
|
2024
Q2 | $22.8M | Buy |
|
|||||
|
2024
Q1 | $17.2M | Buy |
|
|||||
|
2023
Q4 | $13.3M | Buy |
|
|||||
|
2023
Q3 | $8.16M | Buy |
|
|||||
|
2023
Q2 | $6.87M | Sell |
|
|||||
|
2023
Q1 | $7.1M | Buy |
|
|||||
|
2022
Q4 | $3.38M | Sell |
|
|||||
|
2022
Q3 | $4.19M | Sell |
|
|||||
|
2022
Q2 | $4.47M | Sell |
|
|||||
|
2022
Q1 | $5.73M | Sell |
|
|||||
|
2021
Q4 | $11M | Buy |
|
|||||
|
2021
Q3 | $8.61M | Sell |
|
|||||
|
2021
Q2 | $9.85M | Sell |
|
|||||
|
2021
Q1 | $12.6M | Sell |
|
|||||
|
2020
Q4 | $8.46M | Buy |
|
|||||
|
2020
Q3 | $8.02M | Sell |
|
|||||
|
2020
Q2 | $11.4M | Buy |
|
|||||
|
2020
Q1 | $6.98M | Buy |
|
|||||
|
2019
Q4 | $8.07M | Buy |
|
|||||
|
2019
Q3 | $5.92M | Buy |
|
|||||
|
2019
Q2 | $5.52M | Sell |
|
|||||
|
2019
Q1 | $7.83M | Sell |
|
|||||
|
2018
Q4 | $17.6M | Sell |
|
|||||
|
2018
Q3 | $53.4M | Sell |
|
|||||
|
2018
Q2 | $115M | Buy |
|
|||||
|
2018
Q1 | $69.6M | Sell |
|
|||||
|
2017
Q4 | $64.5M | Sell |
|
|||||
|
2017
Q3 | $69.9M | Sell |
|
|||||
|
2017
Q2 | $69.3M | Sell |
|
|||||
|
2017
Q1 | $61.4M | Buy |
|
|||||
|
2016
Q4 | $51.7M | Buy |
|
|||||
|
2016
Q3 | $47.7M | Buy |
|
|||||
|
2016
Q2 | $53M | Sell |
|
|||||
|
2016
Q1 | $48.3M | Buy |
|
|||||
|
2015
Q4 | $42.5M | Sell |
|
|||||
|
2015
Q3 | $33.9M | Buy |
|
|||||
|
2015
Q2 | $31.5M | Sell |
|
|||||
|
2015
Q1 | $24.2M | Sell |
|
|||||
|
2014
Q4 | $17.5M | Sell |
|
|||||
|
2014
Q3 | $16.9M | Buy |
|
|||||
|
2014
Q2 | $5.37M | Buy |
|
|||||
|
2014
Q1 | $4.42M | Sell |
|
|||||
|
2013
Q4 | $6.54M | Sell |
|
|||||
|
2013
Q3 | $18.2M | Sell |
|
|||||
|
2013
Q2 | $16.5M | Buy |
|